Comprehensive Eye Care & Vision Correction in Incheon · Multilingual International Concierge
23+ Years Clinical Experience
en-US
Ophthalmology Guide
Are Stem Cell Treatments the Future for Macular Degeneration?
Discover if stem cell treatments could revolutionize care for macular degeneration. Explore the latest research and future potential. Learn more today!
Schedule a ConsultationIntroduction

If you're reading this because someone you love has macular degeneration—or because you're noticing changes in your own central vision—you're not alone. As our population ages, age-related macular degeneration (AMD) has quietly become one of the most common causes of vision loss worldwide.
What Exactly Are Stem Cell Treatments in AMD?
Let’s start with the basics. AMD affects the macula, the part of your retina responsible for sharp central vision. There are two types:
- Dry AMD (geographic atrophy): Gradual breakdown of light-sensitive cells and the retinal pigment epithelium (RPE).
- Wet AMD: Abnormal blood vessels grow under the retina, leading to sudden and severe vision loss.
Why Stem Cell Therapy Matters So Much

Right now, most AMD treatments focus on slowing the disease—not reversing it.
- For wet AMD, anti-VEGF injections (like Lucentis or Eylea) can stabilize or slightly improve vision.
- For dry AMD, there's little we can do beyond lifestyle modifications and AREDS vitamin supplements.
Where We Are Now: Hype vs. Hope
While the excitement is justified, we also have to be grounded. Stem cell therapy is not yet a routine clinical treatment for AMD. Here’s the honest status:
What’s Been Achieved:
- Early clinical trials show safety and potential efficacy, especially in dry AMD.
- A landmark study at the University of Michigan reported visual improvements in patients who received RPE derived from adult stem cells.
- Stem-cell-derived RPE patches are being refined for safer surgical delivery under the retina.
- New York Stem Cell Foundation is developing standardized, patient-matched RPE cells to avoid immune rejection and streamline therapeutic use.
Remaining Challenges:
- Immune rejection: Even autologous iPSCs can trigger immune responses. Immunosuppressive therapy carries its own risks, especially in older patients.
- Tumor risk: Pluripotent stem cells must be rigorously screened for abnormal growth. Safety protocols must prevent teratoma formation.
- Surgical precision: Implanting cells under the retina requires extreme finesse and safety protocols. The eye is a sensitive and small organ.
- Regulatory approval: Most stem cell therapies for AMD are still classified as experimental worldwide. Reimbursement and insurance pathways are unclear.
- Long-term integration: Will these cells remain functional and safe after 5, 10, or 20 years?
A Patient’s Guide: What Should You Do Now?

If you or a loved one is dealing with AMD, here’s what we recommend from our lens at Global Ubal Eye Center:
1. Ask the Right Questions
- What type of AMD do I have?
- Am I eligible for any clinical trials?
- What are my current treatment options?
- Are there risks in seeking unapproved stem cell therapies abroad?
2. Stay Grounded, Stay Hopeful
Unfortunately, some unlicensed clinics abroad offer "stem cell cures" without real scientific backing. As a rule of thumb, if it sounds too good to be true, it probably is. The Macular Society and American Academy of Ophthalmology have both issued warnings about such practices.
- Has the therapy been through a Phase I or II trial?
- Is it registered with a medical ethics board?
- Will you receive follow-up care for complications?
3. Focus on What You Can Do
Until regenerative therapies become mainstream, there's still a lot you can control:
- Stop smoking.
- Maintain a Mediterranean-style diet rich in leafy greens and omega-3s.
- Use UV-protective sunglasses.
- Get regular eye exams, especially if you have a family history.
- Talk to your doctor about AREDS supplementation if you’re in the intermediate stage of AMD.
Why Global Ubal Eye Center is Watching This Space Closely
At Global Ubal, we're more than just an eye clinic—we're a team committed to long-term patient relationships and personalized care. We see every patient as a partner in their health journey.
Final Thoughts: Are Stem Cells the Future?
In one word: yes. But in three words: not quite yet.
More Articles
Continue reading our ophthalmology guides and vision care insights.
SMILE vs LASIK: Recovery Benchmarks for Vision Correction Care
South Korea has solidified its position as a global epicenter for ophthalmology, with the domestic LASIK and refractive surgery market projected to reach **USD 167.37 million by 2035**, growing at a steady CAGR of 8.54%.
Learn More
Prevalence of Myopia in Korea: The Value of Dream Lens Therapy
The prevalence of myopia among young people in South Korea has reached critical levels, often described as a "myopia epidemic." According to recent data from the **Korean National Health and Nutrition Examination Survey (KNHANES)**, the prevalence of myopia...
Learn More
Multidisciplinary Care: The Future of Korean Pediatric Eye Clinics
The landscape of pediatric eye care in South Korea is shifting rapidly. With nearly **21.9% of Korean children** estimated to be affected by various visual disorders according to nationwide health screenings, the demand for specialized intervention has never...
Learn More